GURUFOCUS.COM » STOCK LIST » USA » NAS » SomaLogic Inc (NAS:SLGC) » Definitions » Earnings Yield (Joel Greenblatt) %
Switch to:

SomaLogic Earnings Yield (Joel Greenblatt) %

: -8.45% (As of Mar. 2022)
View and export this data going back to 2021. Start your Free Trial

SomaLogic's Enterprise Value for the quarter that ended in Mar. 2022 was $813.25 Mil. SomaLogic's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 was $-68.70 Mil. SomaLogic's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2022 was -8.45%.

The historical rank and industry rank for SomaLogic's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

SLGC' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -57.93   Med: -15.95   Max: -4.6
Current: -11.86

During the past 2 years, the highest Earnings Yield (Joel Greenblatt) of SomaLogic was -4.60%. The lowest was -57.93%. And the median was -15.95%.

SLGC's Earnings Yield (Joel Greenblatt) % is ranked worse than
77.45% of 674 companies
in the Healthcare Providers & Services industry
Industry Median: 2.64 vs SLGC: -11.86

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. SomaLogic's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2022 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


SomaLogic Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for SomaLogic's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomaLogic Annual Data
Trend Dec20 Dec21
Earnings Yield (Joel Greenblatt) %
- -5.92

SomaLogic Quarterly Data
Sep20 Dec20 Mar21 Sep21 Dec21 Mar22
Earnings Yield (Joel Greenblatt) % Premium Member Only - - -3.18 -5.92 -8.45

Competitive Comparison

For the Health Information Services subindustry, SomaLogic's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

SomaLogic Earnings Yield (Joel Greenblatt) % Distribution

For the Healthcare Providers & Services industry and Healthcare sector, SomaLogic's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where SomaLogic's Earnings Yield (Joel Greenblatt) % falls into.



SomaLogic Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

SomaLogics Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2021 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-86.223/1455.55928
=-5.92 %

SomaLogic's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-68.70 Mil.



SomaLogic  (NAS:SLGC) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


SomaLogic Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of SomaLogic's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


SomaLogic Business Description

SomaLogic logo
Traded in Other Exchanges
Address
2945 Wilderness Place, Boulder, CO, USA, 80301
SomaLogic Inc delivers precise and actionable health-management information that helps individuals to optimize their personal health and wellness throughout their lives. This information, to be provided through a global network of partners and users, is derived from SomaLogic's personalized measurement of changes in an individual's proteins over time.
Executives
Blakeman Shaun M. officer: Chief Financial Officer C/O CANTEL MEDICAL CORP. 150 CLOVE ROAD LITTLE FALLS NJ 07424
Margulies Anne H. director C/O HENRY SCHEIN, INC. 135 DURYEA ROAD MELVILLE NY 11747
Post Richard A director 998 LACOSTA LANE LANE TREE CO 80124
Casdin Eli director 1350 AVENUE OF THE AMERICAS SUITE 1140 NEW YORK NY 10019
Cox Troy director C/O FOUNDATION MEDICINE, INC. C/O FOUNDATION MEDICINE, INC., 150 SECON CAMBRIDGE MA 02141
Meisel Ted D director
Barchi Robert director
Quake Stephen director C/O FLUIDIGM CORPORATION 7000 SHORELINE COURT, SUITE 100 SOUTH SAN FRANCISCO CA 94080
Lillis Charles M. director 13 CASTLE PINES DRIVE N CASTLE ROCK CO 80108
Harris Melody officer: President and COO 4801 WEST BYRON PLACE DENVER CO 80211
Gutierrez Ruben officer: General Counsel 6435 AVENIDA WILFREDO LA JOLLA CA 92037
Graves Amy officer: Chief Accounting Officer 926 PENDLETON AVENUE LONGMONT CO 80504
Smythe Roy director, officer: Chief Executive Officer 935 10TH STREET BOULDER CO 80302
M-lsh Ii Llc 10 percent owner 667 MADISON AVENUE C/O CORVEX MANAGEMENT LP NEW YORK NY 10065
C-lsh Ii Llc 10 percent owner 1350 6TH AVENUE SUITE 2600 NEW YORK NY 10019

SomaLogic Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)